Advertisement
Singapore markets closed
  • Straits Times Index

    3,287.75
    -5.38 (-0.16%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • Dow

    38,460.92
    -42.77 (-0.11%)
     
  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     
  • Bitcoin USD

    63,976.38
    -2,680.93 (-4.02%)
     
  • CMC Crypto 200

    1,356.80
    -25.77 (-1.86%)
     
  • FTSE 100

    8,098.26
    +57.88 (+0.72%)
     
  • Gold

    2,341.10
    +2.70 (+0.12%)
     
  • Crude Oil

    83.16
    +0.35 (+0.42%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • Nikkei

    37,628.48
    -831.60 (-2.16%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • FTSE Bursa Malaysia

    1,569.25
    -2.23 (-0.14%)
     
  • Jakarta Composite Index

    7,155.29
    -19.24 (-0.27%)
     
  • PSE Index

    6,574.88
    +2.13 (+0.03%)
     

Raffles Medical Group reports FY2023 patmi of $90.2 million, 37.1% lower y-o-y

For the full year, the company posted revenue of $706.9 million, down 14.1% from the $822.9 million recorded in FY2022.

Raffles Medical Group has reported patmi of $90.2 million in FY2023 ended December, 37.1% lower y-o-y on the discontinuance of Covid-19-related activities.

Earnings per share stood at 4.85 cents, compared to the 7.71 cents recorded in FY2022.

For the full year, the company posted revenue of $706.9 million, down 14.1% from the $822.9 million recorded in FY2022.

Upon the resumption of normal movement in China, the company focused on growing and consolidating its three existing hospitals. Revenue for the China region grew 18.1% to $59.3 million in FY2023 from S$50.2 million in FY2022.

ADVERTISEMENT

Cash and cash equivalents stood at $342.5 million as at Dec 31, 2023.

The board has recommended a final core dividend of 2.4 cents per share.

“We are cautiously optimistic in our 2024 outlook. Despite geopolitical and economic headwinds, we see a growing demand for quality healthcare services in Singapore and the region,” says executive chairman Dr Loo Choon Yong.

“Our operational strengths and agility enable us to meet the evolving healthcare and wellness needs of those we serve and care for in Asia,” he adds.

Shares in Raffles Medical Group Bsl closed 1 cent higher or 0.96% up on Feb 23 at $1.05.

 

See Also: